INT15771
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
When NRG1 is presented to Schwann cells in the context of cell-cell contact, type III but not type I NRG1 regulates P0 gene expression. | |||||||||||||||
| |||||||||||||||
|
Increasing evidence from genetic linkage studies has identified both the NRG1 (Stefansson et al., 2002; Harrison and Law, 2006) and the ? | |||||||||||||||
| |||||||||||||||
|
m axonal length; and Nrg1-ECD, 13.20 ± 2.72 clusters/100-? | |||||||||||||||
| |||||||||||||||
|
We also demonstrate that Type III Nrg1 back signaling activates a phosphatidylinositol 3-kinase signaling pathway and that activation of this pathway is required for the insertion of preexisting ? | |||||||||||||||
| |||||||||||||||
|
Additionally, it has been shown that Type III Nrg1 also functions as a receptor, in that Type III Nrg1ErbB interaction results in signaling within the Type III Nrg1expressing cell (Bao et al., 2003, 2004). | |||||||||||||||
| |||||||||||||||
|
Because we do not see effects of Type III Nrg1 back signaling on ? | |||||||||||||||
| |||||||||||||||
|
Stimulation of Type III Nrg1 back signaling increases surface expression of ? | |||||||||||||||
| |||||||||||||||
|
Activation of presynaptic Type III Nrg1 signaling, either by postsynaptic ErbB4 (as shown in Fig. | |||||||||||||||
| |||||||||||||||
|
Prior work has shown that presynaptic Type III Nrg1 is critical for establishing stable interactions with postsynaptic partners and, ultimately, for the survival of neuromuscular synapses as well as for glia development and myelination (Wolpowitz et al., 2000; Michailov et al., 2004; Taveggia et al., 2005; Chen et al., 2006). | |||||||||||||||
| |||||||||||||||
|
Acute stimulation of Type III Nrg1 back signaling increases the number of ? | |||||||||||||||
| |||||||||||||||
|
Stimulation of Type III Nrg1 back signaling induces an increase in axonal surface ? | |||||||||||||||
| |||||||||||||||
|
Presynaptic Type III Neuregulin1-ErbB signaling targets ? | |||||||||||||||
| |||||||||||||||
|
Because we do not see effects of Type III Nrg1 back signaling on ? | |||||||||||||||
| |||||||||||||||
|
As a result, Type III Nrg1 back signaling, by regulating presynaptic ? | |||||||||||||||
| |||||||||||||||
|
Presynaptic Type III Neuregulin1-ErbB signaling targets ? | |||||||||||||||
| |||||||||||||||
|
7* nAChR levels; Type III Nrg1 functioning as a receptor can regulate insertion of preformed ? | |||||||||||||||
| |||||||||||||||
|
It is worth noting that these risk alleles at the NRG1 locus also have been associated with increased expression of Type I and IV Nrg1 (Law et al., 2006). | |||||||||||||||
| |||||||||||||||
|
Reduction of Type III Nrg1 expression results in decreased axonal ? | |||||||||||||||
| |||||||||||||||
|
Subsets of primary sensory neurons within the dorsal root ganglia (DRG) express Type III Nrg1 and ? | |||||||||||||||
| |||||||||||||||
|
Similarly, KU-32 also prevented the NRG1-induced decrease in the expression of the compact myelin protein zero, P0 (Figure 2C). | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.